Plasma proteomic signature of the risk of developing mobility disability: A 9-year follow-up.
Yusuke OsawaRichard D SembaGiovanna FantoniJulián CandiaAngélique BiancottoToshiko TanakaStefania BandinelliLuigi FerrucciPublished in: Aging cell (2020)
CTSS, GDF15, and THBS2 are novel blood biomarkers associated with new mobility disability in community-dwelling individuals. Overall, our analysis suggests that cellular senescence and inflammation should be targeted for prevention of mobility disability.